Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Haynes

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Blood|June 22, 2001
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyA C Rawstron, B Kennedy, P A Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot studyI G McQuaker, A P Haynes, S Anderson, et al.
British Journal of Haematology|March 6, 2008
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaWendy Ingram, Stephen Devereux, Emma P Das-Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase InhibitorsMariana Ferreira Leal, Ben P Haynes, Eugene Schuster, et al.
NPJ Breast Cancer|December 8, 2017
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomyBen P Haynes, Ophira Ginsburg, Qiong Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)Alexandra Leary, Abigail Evans, Stephen R D Johnston, et al.
Blood|September 13, 2003
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsRowena D Faulkner, Charles Craddock, Jennifer L Byrne, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
International Journal of Language & Communication Disorders|May 9, 2001
The public awareness of aphasia: an international surveyC Code, N S Mackie, E Armstrong, et al.
Cytotherapy|August 13, 2002
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusionR J Lush, A P Haynes, J Byrne, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Blood|June 22, 2001
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyA C Rawstron, B Kennedy, P A Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot studyI G McQuaker, A P Haynes, S Anderson, et al.
British Journal of Haematology|March 6, 2008
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphomaWendy Ingram, Stephen Devereux, Emma P Das-Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase InhibitorsMariana Ferreira Leal, Ben P Haynes, Eugene Schuster, et al.
NPJ Breast Cancer|December 8, 2017
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomyBen P Haynes, Ophira Ginsburg, Qiong Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)Alexandra Leary, Abigail Evans, Stephen R D Johnston, et al.
Blood|September 13, 2003
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsRowena D Faulkner, Charles Craddock, Jennifer L Byrne, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
International Journal of Language & Communication Disorders|May 9, 2001
The public awareness of aphasia: an international surveyC Code, N S Mackie, E Armstrong, et al.
Cytotherapy|August 13, 2002
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusionR J Lush, A P Haynes, J Byrne, et al.
Pageof 22